Ardent Health Partners (NYSE:ARDT) Sets New 52-Week Low - What's Next?

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $13.54 and last traded at $13.73, with a volume of 108043 shares traded. The stock had previously closed at $14.20.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ARDT shares. Royal Bank of Canada reduced their price target on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 4th. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Stephens restated an "overweight" rating and set a $22.00 target price on shares of Ardent Health Partners in a research note on Thursday, February 27th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Morgan Stanley dropped their price objective on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $21.18.

Remove Ads

Ardent Health Partners Stock Performance

The company has a fifty day simple moving average of $14.81 and a 200 day simple moving average of $16.67. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, equities research analysts forecast that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Institutional Investors Weigh In On Ardent Health Partners

Several large investors have recently modified their holdings of ARDT. Point72 Asia Singapore Pte. Ltd. bought a new stake in Ardent Health Partners during the fourth quarter valued at $27,000. US Bancorp DE acquired a new position in shares of Ardent Health Partners in the 4th quarter valued at about $31,000. R Squared Ltd bought a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $37,000. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners during the third quarter worth approximately $42,000. Finally, New York State Common Retirement Fund acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.